How is genomics transforming cancer research and treatment? Seven lessons learned from the Festival of Genomics & Biodata 2023 06 Feb 2023 Scientists from around the world, including many ICR researchers, gathered last month at the Festival of Genomics & Biodata in London. Julia Bakker and Diana Cano attended the conference and report back on some of the key take-home messages. Find out more Show/Hide
How reliable are direct-to-consumer genetic tests when interpreting cancer risk? 22 Feb 2022 At-home genetic testing has gained a lot of traction in recent years, raising many ethical issues. Diana Cano talked to world-leading cancer genetics expert Professor Ros Eeles to find out more about the promises and dangers of direct-to-consumer tests in helping to manage cancer risk. Find out more Show/Hide
Sequencing, drugging and interpreting genomes: Where is genomics going next? 02 Feb 2022 The 2022 Festival of Genomics and Biodata took place last week. Our Media Officer Diana Cano reports on some of the talks, with topics ranging from cancer genomics to drug development. Find out more Show/Hide
A targeted prostate cancer screening programme could be possible in five years - what will it look like? 28 Jan 2022
Evolution, cancer and coronavirus – how biology’s ‘Theory of Everything’ is key to fighting cancer and global pandemics 12 Feb 2021